Clinical Trials

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06160362 2023-12-07

The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)

Phase EARLY_PHASE1 Unknown

Lymphoma, Non-Hodgkin

NCT05747157 2023-11-21

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10- 19) in the Treatment of r/r B-ALL Clinical Research

18 enrolled

Burkitt Lymphoma

NCT05950204 2023-07-18

Effect of Supplementation With ω-3 Fatty Acids, Vitamin D and Calcium in Patients With Acute Lymphoblastic Leukemia.

40 enrolled

Vitamin D Deficiency, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04433156 2023-05-18

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

60 enrolled

Lymphoma, B-Cell, Marginal Zone

NCT05385263 2022-05-26

Addition of Nivolumab to Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive DLBCL at Lymphodepletion

Lymphoma, B-Cell

NCT05286164 2022-04-15

Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART

30 enrolled

Lymphoma, B-Cell

NCT05137860 2022-01-18

Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD

56 enrolled

Recurrence, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05133310 2022-01-04

Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia

Classical hematologyLymphoidOther hematologic neoplasm

108 enrolled

Sprains and Strains, Sepsis, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT05164770 2021-12-21

Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Phase 3 Unknown

160 enrolled

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05097443 2021-11-19

Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Phase 3 Unknown

130 enrolled

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT04862806 2021-09-17

Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL

1,000 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT04746092 2021-08-16

The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19

630 enrolled

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT04640064 2020-11-23

Hb A1C Pre and Post Confinement in Latin American Children With Type 1 Diabetes: Dulce Study Group

500 enrolled

Diabetes Mellitus, Type 1, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02772198 2020-11-03

T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell Malignancies

300 enrolled

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04411290 2020-06-02

Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases

EndocrineHead & NeckLymphoid

200 enrolled

Euthyroid Goiter, Thyroid Cancer, Papillary, Burkitt Lymphoma, Goiter, Thyroid Diseases, Thyroid Neoplasms, Thyroid Nodule

NCT02733380 2020-04-01

Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02533700 2020-03-10

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

106 enrolled

DermatologicLymphoid

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Enteropathy-Associated T-Cell Lymphoma

NCT04168788 2019-11-19

MVO

Classical hematologyGenitourinaryLymphoidOther hematologic neoplasm

150 enrolled

Hepatic Veno-Occlusive Disease, Wilms Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04158011 2019-11-08

A Retrospective Study of Patients With Leukemia Relapse in the CNS Treated With CAR T Cells

80 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04158414 2019-11-08

Applying PET/MR in Oncology - a Prospective Project

GastrointestinalGenitourinaryGynecologicHead & NeckLymphoidSarcoma

500 enrolled

Uterine Cervical Neoplasms, Esophageal Neoplasms, Lymphoma, Nasopharyngeal Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT04154228 2019-11-06

Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI

100 enrolled

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin

NCT04152577 2019-11-05

R2 and Combination Chemotherapy Versus R and Combination Chemotherapy in Newly Diagnosed Highly Aggressive B-NHL

200 enrolled

Lymphoma, B-Cell

NCT04134247 2019-10-22

Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL

120 enrolled

Lymphoma, Non-Hodgkin

NCT02747732 2019-04-23

Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL

72 enrolled

Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03569696 2019-04-23

NivoM

50 enrolled

Lymphoma, B-Cell

NCT02526823 2019-04-02

Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma

360 enrolled

Lymphoma

NCT03881761 2019-03-21

CD19/20 Bispecific Nanobody-derived CAR-T Cells in B Cell Lymphoma

50 enrolled

Recurrence, Lymphoma, B-Cell

NCT03881774 2019-03-21

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT03765593 2018-12-05

pSS

100 enrolled

Lymphoma, Lymphoma, Non-Hodgkin

NCT03540303 2018-05-30

Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma

15 enrolled

Lymphoma, Lymphoma, Non-Hodgkin, Recurrence

NCT03413046 2018-01-29

The Effect of Chemotherapy on Regulatory T Cells

60 enrolled

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02924753 2017-12-29

The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).

Burkitt Lymphoma

NCT03263208 2017-10-20

CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.

Burkitt Lymphoma

NCT02488382 2017-10-17

Lonquek for Autologous Stem Cell Mobilization

24 enrolled

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT03267407 2017-09-12

Vietnam Cryptococcal Retention in Care Study - Version 2.1

1,184 enrolled

Acquired Immunodeficiency Syndrome, Cryptococcosis, Mycoses, Mycosis Fungoides, Meningitis, Cryptococcal, AIDS-Related Opportunistic Infections

NCT02265497 2017-08-18

Relinfo

550 enrolled

Lymphoma

NCT03062072 2017-04-07

ECHO

BreastGastrointestinalLymphoid

300 enrolled

Breast Neoplasms, Colonic Neoplasms, Lymphoma, Neoplasms

NCT03022747 2017-01-16

Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol

60 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01079013 2016-04-20

Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

40 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT02507479 2016-04-20

Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

LymphoidOther hematologic neoplasmPlasma cell

24 enrolled

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT02145923 2015-06-10

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Classical hematologyLymphoid

16 enrolled

Anemia, Aplastic, Hodgkin Disease, Enterocolitis, Neutropenic

NCT01300156 2011-02-21

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)

37 enrolled

Hodgkin Disease, Lymphoma, Recurrence

NCT00188084 2005-10-28

Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia

400 enrolled